Aarhus University logo
FMT is considered for patients with recurrent C difficile infection in all Danish hospitals. The use of FMT in Denmark is described in a National Danish clinical guideline.
FMT is used in routine clinical care and in experimental studies throughout Europe. At present, the use of FMT in Europe is unevenly distributed, demonstrated in a Europe-wide survey.
The Council of Europe issues the technical guide for the safety and quality of tissues and cells for human application. Find the current 4th edition of the guide.
Substance of human origin (SoHO) is a term applied by the European Commission to embrace blood, tissues, cells, organs and human-derived material such as breast milk and intestinal microbiota.
Intestinal microbiota is a key determinant of human health. The synergy between host and microbiome affects diseases in all tissues of the human organism.
Use of medical treatments is best investigated by clinical trials. Currently, more than 100 trials investigating the use of FMT in humans are being carried out.